Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patients
- DOI
- 10.1007/s11096-025-01989-x
- Published
- 2025-08-26
- Container
- International Journal of Clinical Pharmacy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11096-025-01989-x,
title = {Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patients},
author = {Hongya Ou and Zijan Tan and Anle Shen and Liting Yu and Yibo He and Ri Hong and Xiaoru Lin and Xiaofeng Shi and Konglang Xing and Xiaoli Song and Yonglin Liu and Lingli Zou and Junyu Li},
year = {2025},
journal = {International Journal of Clinical Pharmacy},
doi = {10.1007/s11096-025-01989-x},
url = {https://doi.org/10.1007/s11096-025-01989-x}
}RIS
TY - JOUR TI - Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patients AU - Hongya Ou AU - Zijan Tan AU - Anle Shen AU - Liting Yu AU - Yibo He AU - Ri Hong AU - Xiaoru Lin AU - Xiaofeng Shi AU - Konglang Xing AU - Xiaoli Song AU - Yonglin Liu AU - Lingli Zou AU - Junyu Li PY - 2025 JO - International Journal of Clinical Pharmacy DO - 10.1007/s11096-025-01989-x UR - https://doi.org/10.1007/s11096-025-01989-x ER -
APA
Ou, H., Tan, Z., Shen, A., Yu, L., He, Y., Hong, R., Lin, X., Shi, X., Xing, K., Song, X., Liu, Y., Zou, L., & Li, J. (2025). Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patients. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-025-01989-x
Source records
- crossref · retrieved 2026-09-25T22:16:53.528Z